Fungal Skin Infection

Embed Size (px)

Citation preview

  • 7/28/2019 Fungal Skin Infection

    1/32

    Fungal Skin Infection

    Irma Savitri

    0806358022

  • 7/28/2019 Fungal Skin Infection

    2/32

    Presentation Outline

    Superficial mycoses

    Pityriasis versicolor

    Candidiasis

    Cutaneous mycoses

    Dermatophytes

  • 7/28/2019 Fungal Skin Infection

    3/32

    Presentation outline

    Aspects that will be discussed in each disease: Etiology

    Risk factors

    Epidemiology

    Histopathology

    Pathophysiology and Pathogenesis

    Clinical manifestation

    Laboratory examination

    Diagnosis, Differential Diagnosis, and Prognosis

    Management

    Prevention

  • 7/28/2019 Fungal Skin Infection

    4/32

    Pityriasis versicolor

  • 7/28/2019 Fungal Skin Infection

    5/32

    Etiology: Malassezia furfur

    GMS stained skin biopsy showingcharacteristic spherical yeast cellsand short pseudohyphal elementstypical ofM. furfur.

    10% KOH with Parker ink mountshowing characteristic sphericalyeast cells and short pseudohyphalelements typical of the fungus.

  • 7/28/2019 Fungal Skin Infection

    6/32

    Risk Factors & Epidemiology

    Risk factors: late teen and young adulthood

    age, tropical and subtropical climate (and to a

    lesser extent temperate climate),

    immunosuppression, malnutrition, use of oral

    contraceptives, hyperhidrosis, poor hygiene

    Epidemiology: commonly found in tropical

    areas

  • 7/28/2019 Fungal Skin Infection

    7/32

    Histopathology: Malassezia furfur

  • 7/28/2019 Fungal Skin Infection

    8/32

    Pathophysiology and Pathogenesis

    Hypopigmentation: tyrosinase inhibitors

    competitively inhibit an enzyme necessary for

    melanocyte pigment formation

    Hyperpigmentation: the organism induces

    enlargement of melanosomes made by

    melanocytes in the basal layer of the epidermis

    In vitro, asparagine stimulates the growth of theorganism, while glycine induces hyphal formation

  • 7/28/2019 Fungal Skin Infection

    9/32

    Clinical Manifestations

    Hypopigmentation Hyperpigmentation

  • 7/28/2019 Fungal Skin Infection

    10/32

    Laboratory Examination

    Skin scraping

    Cellophane stripping technique

  • 7/28/2019 Fungal Skin Infection

    11/32

    Diagnosis, Differential Diagnosis,

    Prognosis, Management

    Woods lamp: golden yellow fluorescence

    Mainly cosmetic problem

    Daily application of selenium sulfide, topicalor oral azole

    Avoid excessive heat and sweating

  • 7/28/2019 Fungal Skin Infection

    12/32

    Woods lamp

  • 7/28/2019 Fungal Skin Infection

    13/32

    Woods lamp

  • 7/28/2019 Fungal Skin Infection

    14/32

    Candidiasis

  • 7/28/2019 Fungal Skin Infection

    15/32

    Etiology: Candida

  • 7/28/2019 Fungal Skin Infection

    16/32

    Risk Factors and Epidemiology

    superficial candidiasis: AIDS, pregnancy,

    diabetes, young or old age, birth control pills,

    and trauma.

    Systemic candidiasis: chronic administration of

    corticosteroids or other immunosuppressive

    agents as well as hematologic diseases.

  • 7/28/2019 Fungal Skin Infection

    17/32

    Histopathology

  • 7/28/2019 Fungal Skin Infection

    18/32

    Pathophysiology and Pathogenesis

    increase in the local census ofCandida anddamage to the skin or epithelium localinvasion by the yeasts and pseudohyphae.

    Systemic candidiasis bloodstream and thephagocytic host defenses are inadequate tocontain the growth and dissemination of theyeasts.

    Important: Cell-mediated immune response,neutrophil

  • 7/28/2019 Fungal Skin Infection

    19/32

    Clinical Manifestation

    Cutaneous and MuscosalCandidiasis

    Candidiasis in theGastrointestinal mucosa

  • 7/28/2019 Fungal Skin Infection

    20/32

  • 7/28/2019 Fungal Skin Infection

    21/32

    Laboratory Examination, Diagnosis,

    Differential Diagnosis, Prognosis

    Swabs and scrapings

    Culture, Gram stain

  • 7/28/2019 Fungal Skin Infection

    22/32

    Management and Prevention

    Thrush and other mucocutaneous forms ofcandidiasis : topical nystatin or oralketoconazole or fluconazole

    Systemic candidiasis: amphotericin B,sometimes in conjunction with oralflucytosine, fluconazole, or caspofungin

    Prevention: avoid disturbing the normalbalance of microbial flora and intact hostdefense

  • 7/28/2019 Fungal Skin Infection

    23/32

    Dermatophytoses

  • 7/28/2019 Fungal Skin Infection

    24/32

    Etiology

    Microsporum

    Epidermophyton floccosum

    Trichophyton

  • 7/28/2019 Fungal Skin Infection

    25/32

    Microsporum

    Microsporum caninum Microsporum gypseum

  • 7/28/2019 Fungal Skin Infection

    26/32

    Risk Factors and Epidemiology

    Moisture, warmth, etc.

    The incidence is higher in hot, humid climates

    and under crowded living conditions.

  • 7/28/2019 Fungal Skin Infection

    27/32

    Histopathology

  • 7/28/2019 Fungal Skin Infection

    28/32

    Pathophysiology and Pathogenesis

    Dermatophytes synthesize keratinases

    digest keratin and sustain existence of fungi in

    keratinized structures.

    Cell-mediated immunity and antimicrobial

    activity of polymorphonuclear leukocytes

    restrict dermatophyte pathogenicity

  • 7/28/2019 Fungal Skin Infection

    29/32

    Clinical Manifestations

    Tinea pedis Tinea pedis

  • 7/28/2019 Fungal Skin Infection

    30/32

    Clinical Manifestations

    Tinea cruris Tinea corporis

  • 7/28/2019 Fungal Skin Infection

    31/32

    Clinical Manifestations

    Tinea manuum

    Laboratory Examination Diagnosis

  • 7/28/2019 Fungal Skin Infection

    32/32

    Laboratory Examination, Diagnosis,

    Differential Diagnosis, Prognosis,

    Management, Prevention Scraping

    Culture on Saboraud agar

    Woods lamp

    Therapy: throrough removal of infected and

    dead epithelial structures and application of a

    topical antifungal or antibiotic

    Prevention: Avoid sources of infection